Novonesis (novozymes) BNVZMF
13F holders, Q4 2025 (December 31)1holders
1new positions
1sold out
$62.47avg. 13F price*
At the end of Q4 2025, 1 institutions reported holding Novonesis (novozymes) B (NVZMF) in their 13F filings, unchanged from Q3 2025. 1 opened new positions and 1 sold out. The largest holder was Trust Co. of Vermont ($41K).
- Company
- Novonesis (novozymes) B
- CUSIP
- K7317J133
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q3 2025 → Q4 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 1 | $41K |
| Exits | 1 | $995K |
All 13F filers, Q3 2025 → Q4 2025: 650 shares bought and 16,253 shares sold, net −15,603 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 1 holders
| Trust Co. of Vermont | 0.00% | New | 650 | $41K |
"% of holder's portfolio" is NVZMF's weight in each manager's 13F, not the share of Novonesis (novozymes) B the manager owns.